Core One Labs Inc.: Core One Labs' Akome Signs Contract with

VANCOUVER, BC / ACCESSWIRE / January 24, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), in follow-up to its press release dated September 16

Related Keywords

Colombia , United States , Canada , Toronto , Ontario , Spain , Barcelona , Comunidad Autonoma De Cataluna , Vancouver , British Columbia , Canadian , Medina Granada , Robertew Hancock , Christian Gri , Boshi Gimpera , Joel Shacker , University Of Barcelona The Investigators , Javeriana University Medical School , Trademark Office , University Of Toronto , Canadian Securities Exchange , Company Or Core , Head Of Scientific Development , University Of Barcelona , Universitat De Barcelona The University Of , Biosciences Inc , Core One Labs Inc , Akome Biotech Ltd , Vocan Biotechnologies Inc , Zone See Company , Health Canada , Core One Labs Inc View , Core One Labs , Akome Biotech , Universitat De Barcelona , Alzheimer Disease , Ischemic Stroke , Neuro Zone Srl , Luniversidad Complutense , United States Patent , Santiago Ferro , Core One , Chief Medical Officer , Chief Executive Officer , Internal Medicine , Infectious Diseases , Chief Execute Officer , Scientific Development , Vocan Biotechnologies , One Labs , Awakened Biosciences Inc , Disclaimer Statement , Controlled Drugs , Substances Act , Core , Labs , Okome , Signs , Contract , University , Initiating , Animal , Model , Studies , Psychedelics , Drug , Development , Combat , Variety , Neurological , Diseases ,